1.46 USD
▲+0.02+2.82%
盘后 1.43 +0.70%
2026-08-03
市值
$72.53M
市盈率
—
EPS
-0.39
股息率
—
52 周区间
0.56 – 3.82
成交量
486.19K
Beta
1.27
目标价
5.40
52W 低 0.5652W 高 3.82
价格走势
公司简介
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its...